After earnings plunge, BioNTech pins hopes on cancer drug launches

Go back to After earnings plunge, BioNTech pins hopes on cancer drug launches
(NASDAQ: BNTX) Delayed: 98.66 -5.1 (4.92%)
Previous Close $103.76    52 Week High
Open $100.24    52 Week Low
Day High $101.33    P/E N/A 
Day Low $98.18    EPS
Volume 1,127,242